All News

The debate on CHADS2 scoring vs. CHA2DS2-VASc continues

A final ruling from CMS states that "We now believe a more targeted and less disruptive approach is warranted"

Okay, pharmacists. All together now. What's the one question you hear all day long?

Experts gave tips on helping prevent crimes focused on retail pharmacy during Protect Your Pharmacy Week in late April

Five men, five different careers: all driven by a common passion for pharmacy

A round-up of apps that can improve the pharmacy bottom line and help with patient care

Because their classification is variable, the taxation of glucose test strips varies from state to state, giving rise to massive confusion and loss of revenue

Ned Milenkovich has been reappointed to the Illinois State Board of Pharmacy for an additional five-year term

As drug reimbursement policies change, one question keeps popping up. What will replace average wholesale price?

The time has come for pharmacists to work on reforming the maximum allowable costs put forth by the pharmacy benefit managers

A survey of new Rx, new generic, and new OTC products

A round-up of OTC products to help manage skin problems

Connecticut's recently enacted law legalizing medical marijuana includes language ensuring that pharmacists who follow state law will be protected from prosecution

A recent study indicated that the cost of diabetes treatment could be reduced if physicians prescribed more generics

Afatinib used in lung cancer treatment helped patients live longer, according to the results of a new phase 3 clinical trial.

Men with advanced prostate cancer treated with enzalutamide (formerly MDV3100) demonstrated a significantly higher response rate in health-related quality of life, according to new data from the phase 3 AFFIRM study.

Label prescribing information for dabigatran (Pradaxa, Boehringer Ingelheim) capsules has been updated to affirm that the 150-mg twice-daily dose is superior to warfarin in reducing ischemic and hemorrhagic strokes in patients with nonvalvular atrial fibrillation.

Daily vitamin D (≤400 IU) and calcium (1,000 mg) supplements for the primary prevention of fractures in postmenopausal women are no longer recommended as they don't help prevent fractures and may cause harm, according to draft guidance from the U.S. Preventive Services Task Force.

U.S. Marshals recently seized misbranded Global Biotechnologies dietary supplements at the request of the FDA, and per a warrant issued by the U.S. District Court for the District of Maine, according to an FDA statement.

Nonsteroidal anti-inflammatory drugs (NSAIDs) may prevent the development of skin cancer, according to a new study, published online first in the journal Cancer on May 29.

With the help of the National Community Pharmacists Association, community pharmacists are taking on the issue of medication nonadherence, which costs the nation about $300 billion each year, the organization announced in a recent statement.

FDA has approved pertuzumab (Perjeta, Roche) in combination with trastuzumab (Herceptin) and docetaxel chemotherapy for the treatment of people with HER2-positive metastatic breast cancer who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.

FDA has approved gabapentin enacarbil (Horizant, GlaxoSmithKline and XenoPort) extended-release tablets for the management of postherpetic neuralgia in adults.

Botanical Laboratories Inc. is recalling 38 bottles of 33.8-oz. "Wellesse Digestive 3 in 1 Health" liquid dietary supplement and 275 bottles of 16-oz. liquid dietary supplement, after a supplier said one of the ingredients could be contaminated with Salmonella, which can be fatal in young children, frail and elderly people, and others with weakened immune systems.

A bill has passed in the U.S. House of Representatives (H.R. 436, the "Protect Medical Innovation Act of 2012") that will allow consumers to purchase OTC medications through their flexible health spending accounts and health savings accounts without first obtaining a prescription.

The American Pharmacists Association's website, www.pharmacist.com, is back online. The organization learned that their computer servers were accessed by an unauthorized person or persons on the evening of May 28, according to a statement on the website. As soon as the information was received, APhA shut down the site to protect users and the content.

Sandoz, a division of Novartis, is voluntarily recalling 10 lots of its generic oral contraceptive Introvale (levonorgestrel and ethinyl estradiol) tablets in the United States, after a consumer reported a packaging flaw.

The industry should collaborate to develop a U.S. Biopharmacopeia Registry of Biopharmaceutical Products to help resolve biosimilar and broader biopharmaceutical nomenclature issues, according to a leading author and publisher.